U.S. Markets open in 1 hr 4 mins

Navidea Biopharmaceuticals, Inc (NAVB)


NYSE MKT - NYSE MKT Delayed Price. Currency in USD
Add to watchlist
0.4495-0.01 (-1.30%)
At close: 4:02PM EDT
People also watch
IMUCMSTXCLSNGALECPRX
Currency in USD

Valuation Measures

Market Cap (intraday) 572.68M
Enterprise Value 3N/A
Trailing P/E 0.94
Forward P/E 1N/A
PEG Ratio (5 yr expected) 1N/A
Price/Sales (ttm)3.36
Price/Book (mrq)3.33
Enterprise Value/Revenue 3N/A
Enterprise Value/EBITDA 6N/A

Financial Highlights

Fiscal Year
Fiscal Year Ends Dec 31, 2016
Most Recent Quarter (mrq)Mar 31, 2017
Profitability
Profit Margin 347.01%
Operating Margin (ttm)-7.47%
Management Effectiveness
Return on Assets (ttm)-4.46%
Return on Equity (ttm)N/A
Income Statement
Revenue (ttm)21.6M
Revenue Per Share (ttm)0.14
Quarterly Revenue Growth (yoy)-87.70%
Gross Profit (ttm)19.67M
EBITDA -1.14M
Net Income Avi to Common (ttm)-14.49M
Diluted EPS (ttm)0.48
Quarterly Earnings Growth (yoy)N/A
Balance Sheet
Total Cash (mrq)13.44M
Total Cash Per Share (mrq)0.08
Total Debt (mrq)2.1M
Total Debt/Equity (mrq)9.40
Current Ratio (mrq)3.12
Book Value Per Share (mrq)0.14
Cash Flow Statement
Operating Cash Flow (ttm)N/A
Levered Free Cash Flow (ttm)N/A

Trading Information

Stock Price History
Beta -0.98
52-Week Change 3-48.25%
S&P500 52-Week Change 314.72%
52 Week High 31.1600
52 Week Low 30.2600
50-Day Moving Average 30.4874
200-Day Moving Average 30.5989
Share Statistics
Avg Vol (3 month) 3824.84k
Avg Vol (10 day) 3237.48k
Shares Outstanding 5161.69M
Float 124.27M
% Held by Insiders 11.14%
% Held by Institutions 135.00%
Shares Short 312.97M
Short Ratio 311.76
Short % of Float 38.37%
Shares Short (prior month) 313.02M
Dividends & Splits
Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 4N/A
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor (new per old) 2N/A
Last Split Date 3N/A